Lunai Bioworks Inc. (RENB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lunai Bioworks Inc.

    NASDAQ: RENB · Real-Time Price · USD
    1.42
    0.00 (0.00%)
    At close: Jun 09, 2025, 3:59 PM

    Lunai Bioworks Cash Flow Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022
    Net Income
    		 -80.65M -39.68M -113.43M
    Depreciation & Amortization
    		 121.86K 113.5K 123.59K
    Stock-Based Compensation
    		 4.67M 3.54M 5.49M
    Other Working Capital
    		 5.86M 410.16K 332.21K
    Other Non-Cash Items
    		 56.07M 995.8K -2.6M
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 8.81M 4.31M 1.42M
    Operating Cash Flow
    		 -10.97M -11.77M -15.73M
    Capital Expenditures
    		 -70.43K -29.77K -5.16K
    Cash Acquisitions
    		 65.85K n/a n/a
    Purchase of Investments
    		 n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 -1.26M n/a n/a
    Investing Cash Flow
    		 -1.26M -29.77K -5.16K
    Debt Repayment
    		 8.05M -1.12M -560.85K
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 -528.21K 1.63M 134.91K
    Financial Cash Flow
    		 10.52M 4.52M 4.25M
    Net Cash Flow
    		 -1.65M -7.3M -11.49M
    Free Cash Flow
    		 -11.04M -11.8M -15.74M

    Add to Watchlist